Accelmed Partners has announced it has invested $35 million in SKNV.
SKNV, based in Pompano Beach, Fla., develops medications and skincare solutions for dermatology practices. Founded in 2016 and formerly Sincerus Pharmaceuticals and Prescriber’s Choice, SKNV states it produces medicines for the 12 most common dermatological diagnoses.
Accelmed, based in Aventura, Fla., is a private equity firm focused on acquiring and investing in U.S. commercial stage, lower middle market health technology companies. Founded in 2009, the firm targets equity investments of $10 million to $50 million per transaction in medical devices, diagnostics, digital health and technology-enabled healthcare services.
A press release on the investment noted that proceeds from the round will be used to help SKNV advance its new manufacturing facility, scale its digital health platform, increase its sales team footprint across the United States and expand its management team.